Physician profile
Brian T Durkin
NPI 1790713162
$454,877.54
in general payments reported to CMS, 2019-2025
65 companies · $93K in 2025
The $93K reported for 2025 was more than what 99% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $36K · 2021: $35K · 2022: $110K · 2023: $78K · 2024: $88K · 2025: $93K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $162K · Consulting Fee: $43K · Travel and Lodging: $19K · Food and Beverage: $19K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $10K · Grant: $5,000 · Entertainment: $68.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $162,182.50 |
| Consulting Fee | $43,170.00 |
| Travel and Lodging | $19,184.74 |
| Food and Beverage | $18,624.37 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $10,140.00 |
| Grant | $5,000.00 |
| Entertainment | $68.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $188,693.85 | 2019-2023 | Intracept |
| Boston Scientific Corporation | $121,259.04 | 2020-2025 | Intracept, Wavewriter Alpha Prime 16, General - Therapies |
| Vertos Medical, INC. | $50,699.78 | 2019-2024 | Mild Device Kit |
| Nevro Corp. | $39,102.91 | 2019-2024 | Senza, Omnia |
| Abbott Laboratories | $11,015.75 | 2019-2025 | Proclaim, Eterna |
| Avanos Medical | $9,277.67 | 2019-2022 | |
| Foundation Fusion Solutions, LLC | $5,961.05 | 2021-2025 | |
| Mml US, INC. | $5,657.89 | 2022-2025 | Reactiv8 |
| Globus Medical, INC. | $4,927.25 | 2025 | Senza |
| Stryker Corporation | $4,699.31 | 2021-2025 | Mild Device Kit, Omnicurve, Spinejack |
| Virtus Pharmaceuticals LLC | $1,358.74 | 2020-2021 | |
| Nalu Medical, INC. | $1,297.06 | 2021-2025 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $1,251.94 | 2019-2025 | Sprint Pns System |
| Amgen INC. | $658.15 | 2019-2022 | |
| Daiichi Sankyo INC. | $633.14 | 2019 |
Show all 65 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Durkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.